Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05OVR
|
|||
| Former ID |
DIB011146
|
|||
| Drug Name |
ALP-242
|
|||
| Synonyms |
Antileukoproteinases, Grunenthal
Click to Show/Hide
|
|||
| Indication | Cystic fibrosis [ICD-11: CA25; ICD-10: E84, E84.9; ICD-9: 277] | Terminated | [1] | |
| Company |
Grunenthal GmbH
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Protease unspecific (PRO) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005125) | |||
| REF 2 | Oxidation resistant muteins of antileukoproteinase as potential therapeutic agents. Agents Actions Suppl. 1993;42:111-21. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.